NASDAQ · Medical - Devices

Xylo Technologies Ltd. (MDGS) Stock

$2.36 +10.28% NASDAQ: MDGS Healthcare

Xylo Technologies Ltd. operates as a technology-focused enterprise, providing a comprehensive range of medical devices and related products to international markets, encompassing the United States, Europe, Asia, and Israel.

Valuation

MetricValue
Price$2.36
Market Cap$178.86M
P/E Ratio-0.01
P/B Ratio7.45
P/S Ratio1.95
EPS (TTM)$-9.50
52-Week High$7.17
52-Week Low$1.54
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-51.10%
ROA-25.08%
ROCE-67.35%
Gross Margin12.91%
Operating Margin-25.43%
Net Margin-17.47%
Debt/Equity0.42
Current Ratio1.08

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$1.0M$10.0M$92.0M$92.0M
Operating Profit$-14.0M$-7.0M$-8.0M$-14.0M$-23.0M
Net Profit$-14.0M$-7.0M$4.0M$-10.0M$-16.0M
EPS$-2.72$-0.77$0.13$-6.28$-9.50
Op Margin-5282.1%-1390.6%-81.0%-15.0%-25.4%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$13.0M$32.0M$60.0M$98.0M$64.0M
Total Liabilities$5.0M$6.0M$8.0M$43.0M$31.0M
Cash$7.0M$22.0M$24.0M$20.0M$9.0M
Borrowings$0$0$2.0M$10.0M$10.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-3.0M$-6.0M$-5.0M$-6.0M$-6.0M
Investing Cash Flow$-4.0M$-2.0M$-13.0M$-5.0M$-3.0M
Financing Cash Flow$3.0M$0$19.0M$7.0M$-3.0M
Net Cash Flow$-4.0M$15.0M$2.0M$-4.0M$-11.0M
Free Cash Flow$-3.0M$-6.0M$-5.0M$-6.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-6.57
FCF Yield-4.47%
Quick Ratio1.00
Interest Coverage-15.22
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APTOAptose Biosciences Inc. $1.71 +100.00% -0.16 $4.36M 0.00%
GMDAGamida Cell Ltd. $0.03 +0.00% -0.08 $4.34M 0.00%
HILSHillstream BioPharma, Inc. $0.24 +5.66% -0.66 $4.17M 0.00%
MNKMallinckrodt plc $0.34 -14.97% -0.02 $4.52M 0.00%
NBRVFNabriva Therapeutics plc $0.00 — 0.00 $323 0.00%

About Xylo Technologies Ltd.

Xylo Technologies Ltd. operates as a technology-focused enterprise, providing a comprehensive range of medical devices and related products to international markets, encompassing the United States, Europe, Asia, and Israel. The company's diverse operations are organized into several distinct segments, including Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and other divisions. Among its medical innovations is the Medigus Ultrasonic Surgical Endostapler, an advanced endoscopy system specifically utilized for treating gastroesophageal reflux disease. Xylo Technologies also develops specialized biological gels, engineered to safeguard patients against biological threats and to minimize the intrusion of allergens and viruses through the upper respiratory passages and ocular areas. Beyond its healthcare offerings, the company maintains a significant presence in the digital sector. This includes furnishing a digital advertising platform, managing various online retail outlets for consumer products on the Amazon marketplace, and operating an online platform for event management and ticketing services. Furthermore, Xylo Technologies is actively engaged in pioneering wireless battery charging technologies for vehicles and developing modular electronic vehicles. The organization, which was previously known as Medigus Ltd., officially adopted its current name, Xylo Technologies Ltd., in April 2024. Established in 1999, the company maintains its corporate headquarters in Tel Aviv-Yafo, Israel.

Xylo Technologies Ltd. is headquartered in IL.

Xylo Technologies Ltd. (MDGS) stock trades at $2.36 with a market capitalization of $178.86M. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of 7.45, price-to-sales of 1.95. Over the past 52 weeks the stock has ranged between $1.54 and $7.17, and currently trades 67.1% below its 52-week high.

On profitability, Xylo Technologies Ltd. generates a return on equity (ROE) of -51.10%, return on capital employed of -67.35%, an operating margin of -25.43%, a net profit margin of -17.47%.

Official website: www.medigus.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides